How many FDA warning letters has Inspire Medical Systems Inc. received?

Argus HQ has not recorded an FDA warning letter for Inspire Medical Systems Inc. in our current dataset.

What FDA recalls has Inspire Medical Systems Inc. issued?

Argus HQ has recorded 2 FDA recalls tied to Inspire Medical Systems Inc..

Is Inspire Medical Systems Inc. FDA compliant?

Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 2 recalls, and 0 approval records for Inspire Medical Systems Inc.. Review the linked FDA source records directly before drawing a compliance conclusion.

.hq

company

Inspire Medical Systems Inc.

Name: FDA Enforcement Actions Against Inspire Medical Systems Inc.
Creator: Argus HQ
License: https://argushq.ai/methodology

Jurisdiction: US

FDA Warning Letter timeline

V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.

fda_recall · device_recall2026-06-24
Inspire Medical Systems Inc. — Class II recall: Brand Name: Inspire Medical Systems, Inc. Product Name: Inspire Respiratory Sen…
fda_recall · device_recall2026-06-24
Inspire Medical Systems Inc. — Class II recall: Brand Name: Inspire Medical Systems, Inc. Product Name: Inspire stimulation Lea…

Frequently asked questions

How many FDA warning letters has Inspire Medical Systems Inc. received?: Argus HQ has not recorded an FDA warning letter for Inspire Medical Systems Inc. in our current dataset.
What FDA recalls has Inspire Medical Systems Inc. issued?: Argus HQ has recorded 2 FDA recalls tied to Inspire Medical Systems Inc..
Is Inspire Medical Systems Inc. FDA compliant?: Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 2 recalls, and 0 approval records for Inspire Medical Systems Inc.. Review the linked FDA source records directly before drawing a compliance conclusion.

Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.